Kronos Bio, Inc. (KRON)

Kronos Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	6.29	0	0	0	0
Gross Profit	6.29	0	0	0	0
Selling, General & Admin	41.74	43.4	38.5	14.79	3.37
Research & Development	86.38	93.72	112.9	43.25	13.45
Operating Expenses	128.12	137.12	151.4	58.04	16.82
Operating Income	-121.83	-137.12	-151.4	-58.04	-16.82
Interest Expense / Income	0	0	0	3.89	0
Other Expense / Income	-9.16	-3.91	-0.32	26.51	-0.7
Pretax Income	-112.67	-133.2	-151.08	-88.44	-16.12
Net Income	-112.67	-133.2	-151.08	-88.44	-16.12
Shares Outstanding (Basic)	58	56	55	16	5
Shares Outstanding (Diluted)	58	56	55	16	5
Shares Change	2.75%	2.64%	236.38%	208.35%	8.69%
EPS (Basic)	-1.95	-2.37	-2.76	-5.43	-3.05
EPS (Diluted)	-1.95	-2.37	-2.76	-5.43	-3.05
Free Cash Flow	-79.26	-91.5	-122.18	-47.48	-18.03
Free Cash Flow Per Share	-1.37	-1.63	-2.23	-2.92	-3.42
Gross Margin	100.00%	-	-	-	-
Operating Margin	-1937.50%	-	-	-	-
Profit Margin	-1791.87%	-	-	-	-
Free Cash Flow Margin	-1260.51%	-	-	-	-
EBITDA	-107.76	-128.74	-147	-79.69	-15.51
EBITDA Margin	-1713.69%	-	-	-	-
Depreciation & Amortization	4.92	4.46	4.08	4.87	0.61
EBIT	-112.67	-133.2	-151.08	-84.55	-16.11
EBIT Margin	-1791.87%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).